Report Detail
Global Human Rabies Immunoglobulin (IM) Market Growth 2019-2024
- RnM3035552 |
- 27 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU.
Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%.
China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.
According to this study, over the next five years the Human Rabies Immunoglobulin (IM) market will register a 8.0% CAGR in terms of revenue, the global market size will reach US$ 450 million by 2024, from US$ 290 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Rabies Immunoglobulin (IM) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions and countries.
This study considers the Human Rabies Immunoglobulin (IM) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
ERIG
HRIG
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Category II Exposure
Category III Exposure
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Rabies Immunoglobulin (IM) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Human Rabies Immunoglobulin (IM) market by identifying its various subsegments.
Focuses on the key global Human Rabies Immunoglobulin (IM) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Rabies Immunoglobulin (IM) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Rabies Immunoglobulin (IM) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Human Rabies Immunoglobulin (IM) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Human Rabies Immunoglobulin (IM) Consumption 2014-2024
- 2.1.2 Human Rabies Immunoglobulin (IM) Consumption CAGR by Region
- 2.2 Human Rabies Immunoglobulin (IM) Segment by Type
- 2.2.1 ERIG
- 2.2.2 HRIG
- 2.3 Human Rabies Immunoglobulin (IM) Consumption by Type
- 2.3.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2014-2019)
- 2.4 Human Rabies Immunoglobulin (IM) Segment by Application
- 2.4.1 Category II Exposure
- 2.4.2 Category III Exposure
- 2.5 Human Rabies Immunoglobulin (IM) Consumption by Application
- 2.5.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Human Rabies Immunoglobulin (IM) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2014-2019)
3 Global Human Rabies Immunoglobulin (IM) by Players
- 3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players
- 3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2017-2019)
- 3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2017-2019)
- 3.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players
- 3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Players (2017-2019)
- 3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2017-2019)
- 3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Players
- 3.4 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Human Rabies Immunoglobulin (IM) by Regions
- 4.1 Human Rabies Immunoglobulin (IM) by Regions
- 4.1.1 Global Human Rabies Immunoglobulin (IM) Consumption by Regions
- 4.1.2 Global Human Rabies Immunoglobulin (IM) Value by Regions
- 4.2 Americas Human Rabies Immunoglobulin (IM) Consumption Growth
- 4.3 APAC Human Rabies Immunoglobulin (IM) Consumption Growth
- 4.4 Europe Human Rabies Immunoglobulin (IM) Consumption Growth
- 4.5 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Growth
5 Americas
- 5.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries
- 5.1.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
- 5.1.2 Americas Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
- 5.2 Americas Human Rabies Immunoglobulin (IM) Consumption by Type
- 5.3 Americas Human Rabies Immunoglobulin (IM) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries
- 6.1.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
- 6.1.2 APAC Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
- 6.2 APAC Human Rabies Immunoglobulin (IM) Consumption by Type
- 6.3 APAC Human Rabies Immunoglobulin (IM) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Human Rabies Immunoglobulin (IM) by Countries
- 7.1.1 Europe Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
- 7.1.2 Europe Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
- 7.2 Europe Human Rabies Immunoglobulin (IM) Consumption by Type
- 7.3 Europe Human Rabies Immunoglobulin (IM) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) by Countries
- 8.1.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Type
- 8.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Human Rabies Immunoglobulin (IM) Distributors
- 10.3 Human Rabies Immunoglobulin (IM) Customer
11 Global Human Rabies Immunoglobulin (IM) Market Forecast
- 11.1 Global Human Rabies Immunoglobulin (IM) Consumption Forecast (2019-2024)
- 11.2 Global Human Rabies Immunoglobulin (IM) Forecast by Regions
- 11.2.1 Global Human Rabies Immunoglobulin (IM) Forecast by Regions (2019-2024)
- 11.2.2 Global Human Rabies Immunoglobulin (IM) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Human Rabies Immunoglobulin (IM) Forecast by Type
- 11.8 Global Human Rabies Immunoglobulin (IM) Forecast by Application
12 Key Players Analysis
- 12.1 CSL Behring
- 12.1.1 Company Details
- 12.1.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CSL Behring News
- 12.2 Grifols
- 12.2.1 Company Details
- 12.2.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Grifols News
- 12.3 Sanofi
- 12.3.1 Company Details
- 12.3.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Sanofi News
- 12.4 Sichuan Yuanda Shuyang
- 12.4.1 Company Details
- 12.4.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sichuan Yuanda Shuyang News
- 12.5 CNBG
- 12.5.1 Company Details
- 12.5.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 CNBG News
- 12.6 Kamada
- 12.6.1 Company Details
- 12.6.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Kamada News
- 12.7 CBPO
- 12.7.1 Company Details
- 12.7.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 CBPO News
- 12.8 Shuanglin Bio
- 12.8.1 Company Details
- 12.8.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Shuanglin Bio News
- 12.9 Weiguang Bio
- 12.9.1 Company Details
- 12.9.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Weiguang Bio News
- 12.10 Shanghai RAAS
- 12.10.1 Company Details
- 12.10.2 Human Rabies Immunoglobulin (IM) Product Offered
- 12.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Shanghai RAAS News
- 12.11 Bharat Serum
- 12.12 VINS
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Human Rabies Immunoglobulin (IM) . Industry analysis & Market Report on Human Rabies Immunoglobulin (IM) is a syndicated market report, published as Global Human Rabies Immunoglobulin (IM) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Human Rabies Immunoglobulin (IM) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
